Toronto, Ontario – TheNewswire - January 28, 2026 – Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation", TSXV:VPT) is pleased to announce that it received approval from the TSX Venture Exchange (“TSXV”) and has issued 4,276,964 common shares (the “Shares”) of the Corporation to settle an aggregate of $427,696.35 of debt owed to certain arm’s length creditors of the Corporation at a price of$0.10 per share.  The Shares are subject to a hold period of four months and one day. The Corporation d ...